Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

AstraZeneca

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00859560

NIS-OJP-ARI-2007/1

Details and patient eligibility

About

The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience investigation.

Enrollment: 2,205 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Post-menopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation.

Exclusion criteria